Lucid Dreaming Pharmaceutical Active Ingredients CAS 357-70-0 Galantamine For Alzheimer's Disease
10g
MOQ
negotiate
Price
Lucid Dreaming Pharmaceutical Active Ingredients CAS 357-70-0 Galantamine For Alzheimer's Disease
Features Gallery Product Description Request A Quote
Features
Basic Infomation
Place of Origin: China
Brand Name: Yuan Cheng
Certification: ISO9001
Model Number: 357-70-0
High Light:

medicine raw material

,

raw materials testing pharmaceutical

Payment & Shipping Terms
Packaging Details: Discreet package
Delivery Time: 4-7 work days
Payment Terms: Bank transfer,,MoneyGram,Bitcoin
Supply Ability: 5000kg/m
Specifications
Chemical Name: Galantamine
Appearance: White Powder
Email: Kevin@chembj.com
Purity: 99%
Whatsapp: +86 15372415908
Grade: Pharmaceutical Grade
CAS: 357-70-0
MF: C17H22ClNO3
MW: 323.8145
Product Description

Lucid Dreaming CAS 357-70-0 Galantamine for the treatment of mild to moderate Alzheimer's disease

CAS 357-70-0 Galantamine

Product Name: Galantamine
Alias: Galanthamine
CAS: 357-70-0
MF: C17H22ClNO3
MW: 323.8145
Purity: 99%
MP: 119-121°C
BP: 439.3°C at 760 mmHg
FP: 219.5°C
Grade: Pharmaceutical Grade
Appearance: White Powder

 

Galantamine is used for the treatment of mild to moderate Alzheimer's disease and various other memory impairments, in particular those of vascular origin. In addition to uses in Alzheimer's disease, galantamine has been used to treat myasthenia, myopathy, muscular dystrophy, and sensory and motor dysfunction associated with disorders of the central nervous system. Research has indicated that galantamine may prove useful both in the treatment of organophosphate poisoning and in the treatment of autism in children and adolescents.

 

 

Side Effects

 

 

Galantamine's side effect profile was very similar to that of other cholinesterase inhibitors, with gastrointestinal symptoms being the most notable and most commonly observed. One study reports higher proportions of patients treated with galantamine experiencing nausea and vomiting as opposed to the placebo group. Another study using a dose-escalation treatment has found that incidences of nausea would decrease to baseline levels soon after each increase in administered dosage. In practice, some other cholinesterase inhibitors might be better tolerated; however, a careful and gradual titration over more than three months may lead to equivalent long-term tolerability.

Lucid Dreaming Pharmaceutical Active Ingredients CAS 357-70-0 Galantamine For Alzheimer's Disease 0Lucid Dreaming Pharmaceutical Active Ingredients CAS 357-70-0 Galantamine For Alzheimer's Disease 1

If you are interested inTrestolone,please contact: 
Whatsapp:+86 15372415908

Recommended Products
Get in touch with us
Contact Person : Lisa
Fax : 86-27-88308150-803
Characters Remaining(20/3000)